Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07548632 · ClinicalTrials.gov registry record · Phase 2
A Clinical Study Evaluating Licaminlimab for Dry Eye Disease
A Phase 2 study, sponsored by Oculis.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 160
- Enrollment target
NCT07548632 is a Phase 2 study that is actively recruiting participants, run by Oculis. The registered enrollment target is 160 participants.
The verdict
NCT07548632, a Phase 2 study, is actively recruiting participants, sponsored by Oculis.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 160 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
Interventions
- OTHER Artificial Tear Run-in
- DRUG licaminlimab
- OTHER Vehicle of licaminlimab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2026-04-16 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07548632
The ClinicalTrials.gov registry entry for NCT07548632 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oculis, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Artificial Tear Run-in is the first listed.
NCT07548632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07548632 about?
NCT07548632 is a clinical study titled "A Clinical Study Evaluating Licaminlimab for Dry Eye Disease". The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a specific genotype.
What is the current status of trial NCT07548632?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 160 participants. The study started on 2026-04-16. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07548632?
The interventions under investigation include: Artificial Tear Run-in (OTHER), licaminlimab (DRUG), Vehicle of licaminlimab (OTHER).
Who is sponsoring clinical trial NCT07548632?
This trial is sponsored by Oculis, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.